Particle.news
Download on the App Store

Colts Target Week 1 Return for Alec Pierce After GM Denies Second PRP Injection

The clarification reduces immediate worry about his rehab as the team manages a thin wide receiver room following the Michael Pittman Jr. trade.

Overview

  • Colts general manager Chris Ballard said Tuesday that Pierce has made steady progress, has suffered no rehab setbacks, and the team is planning for him to be available for the regular-season opener.
  • Ballard denied that Pierce received a second platelet-rich plasma (PRP) injection after his March ankle and heel surgery and confirmed the only PRP shot came in January.
  • Pierce remains on the Physically Unable to Perform list, traveled to Foxborough with the team, and worked in the rehab group doing conditioning and individual drills rather than full-team practice.
  • Initial reports that Pierce had a second PRP treatment were corrected by local follow-up reporting and by Ballard, highlighting a short media–team communication breakdown over his recovery.
  • Pierce’s recovery carries roster consequences because the Colts re-signed him to a four-year, $114 million deal and traded Michael Pittman Jr., leaving Indianapolis to manage depth with short-term signings and limited reps until Pierce is cleared.